Your browser doesn't support javascript.
loading
Two novel TSC2 mutations in renal epithelioid angiomyolipoma sensitive to everolimus.
Wang, Tao; Xie, Shunqiang; Luo, Rongtuan; Shi, Lianguo; Bai, Peide; Wang, Xuegang; Wan, Rui; Deng, Jiang; Wu, Zhun; Li, Wei; Xiao, Wen; Wang, Yongfeng; Chen, Bin; Zhang, Kaiyan; Xing, Jinchun.
Afiliação
  • Wang T; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Xie S; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Luo R; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Shi L; Department of Pathology, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Bai P; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Wang X; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Wan R; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Deng J; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Wu Z; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Li W; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Xiao W; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Wang Y; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Chen B; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Zhang K; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Xing J; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
Cancer Biol Ther ; 21(1): 4-11, 2020.
Article em En | MEDLINE | ID: mdl-31597506
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Epitelioides / Angiomiolipoma / Everolimo / Neoplasias Renais / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Female / Humans / Middle aged Idioma: En Revista: Cancer Biol Ther Assunto da revista: NEOPLASIAS / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Epitelioides / Angiomiolipoma / Everolimo / Neoplasias Renais / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Female / Humans / Middle aged Idioma: En Revista: Cancer Biol Ther Assunto da revista: NEOPLASIAS / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos